Regulatory actions for March 24-30, 2020 March 31, 2020 Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Algernon, Astrazeneca, Beyondspring, Cstone, Daiichi Sankyo, Eisai, EMD Serono, Exelixis, Gilead Sciences, Humanigen, I-Mab, Junshi, Lupin, Mylan, Neurorx, Relief, Samsung Bioepis, Shenzhen Chipscreen Biosciences, Sumitomo Dainippon, Takeda.Read More
Clinical data for March 24-30, 2020 March 31, 2020 Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Altasciences, Cytodyn, Eagle, Healios, Immutep, Medimetriks, Opthea, Otsuka, Partner, Pluristem, Qurient, Regeneron, Revive, Roivant Sciences, Sanofi, Symbio.Read More
Appointments and advancements for March 31, 2020 March 31, 2020 New hires and promotions in the biopharma industry in Asia-Pacific, including: I-Mab Biopharma, Sosei Group.Read More
Other news to note for March 31, 2020 March 31, 2020 Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Airon, Aroa Biosurgery, Battelle, Behold.ai Technologies, Carterra, Cubic, Dräger, Echosens, Evqlv, Ford, GE Healthcare, General Motors, Houston Methodist Hospital, Immunoprecise Antibodies, JR Automation, Luminati, Luminex, Metaphy Health, Navidea Biopharmaceuticals, Neumodx, Northwell Health, NTI Nanotechnology, Ozo Life, Phillips-Medsize, Procept, Sectra, Sense Biodetection, Stagezero Life Sciences, Viral Protection Labs, Virgin Orbit, Wellbeing Software, Worldcare Clinical.Read More
In the clinic for March 31, 2020 March 31, 2020 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards, Grail, Pixium Vision.Read More
Financings for March 31, 2020 March 31, 2020 Med-tech firms raising money in public or private financings, including: Artio Medical, Icad, Orthospin, Pavmed.Read More
Appointments and advancements for March 31, 2020 March 31, 2020 New hires and promotions in the med-tech industry, including: Bellaseno, Iridex, S4 Medical.Read More
Regulatory actions for March 31, 2020 March 31, 2020 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Agios, Astrazeneca, Bluebird, BMS, Cytodyn, Essa, GW, Intellia, Takeda, Zealand.Read More
Other news to note for March 31, 2020 March 31, 2020 Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Anavex, Bionomics, Boehringer Ingelheim, Brii, Carterra, Cytomx, Dyne, Evotec, Excellabio, Gedeon Richter, Genfit, Green Cross, Horizon, Ildong, Immunoprecise, Index, Junshi, Kleo, Lee’s Myovant, Newron, Nuvo, Oxford, Orgenesis, Otsuka, Pharmahungary, Phio, Predictive, Primmune, SAB, Sirona, Takeda, Vaxart, VBI, Viscient, Windtree.Read More
In the clinic for March 31, 2020 March 31, 2020 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Bausch, Biocardia, Biomx, Chimed, Dicerna, Eyegate, Genfit, GT Biopharma, Iterum, Kiniksa, Matinas, Mersana, Mimetogen, Orphomed, Proqr, Reata, Synairgen, Verona, Xenon.Read More